Axsome Therapeutics, Inc. ($AXSM)
Filing Information
| Accession Number | 0001193125-26-264035 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 9, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
99,000
Total Value
$8,038,470.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Jun 9, 2026 | Exercise/Conversion | 33,000 | $3.50 | $115,500.00 | 75,867 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Jun 9, 2026 | Sale | 33,000 | $240.09 | $7,922,970.00 | 42,867 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Jun 9, 2026 | Exercise/Conversion | 33,000 | $0.00 | $0.00 | 72,000 | Direct | โ | View Details |